Literature DB >> 11518568

Concentration-dependent, temperature-dependent non-Newtonian viscosity of lung surfactant dispersions.

D M King1, Z Wang, J W Kendig, H J Palmer, B A Holm, R H Notter.   

Abstract

The bulk shear viscosities of aqueous dispersions of lavaged calf lung surfactant (LS) and its chloroform:methanol extract (CLSE) were measured as a function of concentration, shear rate and temperature. At 10-mg phospholipid per milliliter, dispersions of LS and vortexed CLSE in 0.15 M NaCl (saline) had low viscosities near 1 cp over a range of shear rates from 225 to 1125 s(-1). Lung surfactant viscosity increased with phospholipid concentration and became strongly non-Newtonian with higher values at low shear rates. At 37 degrees C and 40 mg/ml, LS and vortexed CLSE in saline had viscosities of 38 and 34 cp (77 s(-1)) and 12 and 7 cp (770 s(-1)), respectively. Viscosity values for LS and CLSE were dependent on temperature and, at fixed shear, were lower at 23 degrees C than at 37 or 10 degrees C. Hysteresis was also present in viscosity measurements depending on whether shear rate was successively increased or decreased during study. Addition of 5 mM Ca(2+) at 37 degrees C markedly reduced CLSE viscosity at all shear rates and decreased LS viscosity at low shear rates. Dispersion by sonication rather than vortexing increased the viscosity of CLSE at fixed shear, while synthetic phospholipids dispersed by either method had low, relatively Newtonian viscosities. The complex viscous behavior of dispersions of LS and CLSE in saline results from their heterogeneous aggregated microstructure of phospholipids and apoproteins. Viscosity is influenced not only by the aggregate surface area under shear, but also by phospholipid-apoprotein interactions and aggregate structure/deformability. Similar complexities likely affect the viscosities of biologically-derived exogenous surfactant preparations administered to patients in clinical surfactant therapy.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11518568     DOI: 10.1016/s0009-3084(01)00150-5

Source DB:  PubMed          Journal:  Chem Phys Lipids        ISSN: 0009-3084            Impact factor:   3.329


  7 in total

Review 1.  Surfactant therapy for acute lung injury and acute respiratory distress syndrome.

Authors:  Krishnan Raghavendran; D Willson; R H Notter
Journal:  Crit Care Clin       Date:  2011-07       Impact factor: 3.598

2.  The viscosity and glycoprotein biochemistry of salmonid mucus varies with species, salinity and the presence of amoebic gill disease.

Authors:  Shane D Roberts; Mark D Powell
Journal:  J Comp Physiol B       Date:  2004-10-29       Impact factor: 2.200

Review 3.  Surfactant for pediatric acute lung injury.

Authors:  Douglas F Willson; Patricia R Chess; Robert H Notter
Journal:  Pediatr Clin North Am       Date:  2008-06       Impact factor: 3.278

4.  Kinematic viscosity of therapeutic pulmonary surfactants with added polymers.

Authors:  Karen W Lu; Jesús Pérez-Gil; H William Taeusch
Journal:  Biochim Biophys Acta       Date:  2009-03

5.  Bilayer aggregate microstructure determines viscoelasticity of lung surfactant suspensions.

Authors:  Clara O Ciutara; Joseph A Zasadzinski
Journal:  Soft Matter       Date:  2021-05-26       Impact factor: 4.046

6.  Synthetic lung surfactants containing SP-B and SP-C peptides plus novel phospholipase-resistant lipids or glycerophospholipids.

Authors:  Robert H Notter; Rohun Gupta; Adrian L Schwan; Zhengdong Wang; Mohanad Gh Shkoor; Frans J Walther
Journal:  PeerJ       Date:  2016-10-27       Impact factor: 2.984

Review 7.  Determination of rheology and surface tension of airway surface liquid: a review of clinical relevance and measurement techniques.

Authors:  Zhenglong Chen; Ming Zhong; Yuzhou Luo; Linhong Deng; Zhaoyan Hu; Yuanlin Song
Journal:  Respir Res       Date:  2019-12-04
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.